Pharmaceutical drug classification
ATC code C: Cardiovascular system |
---|
- C01 Cardiac therapy
- C02 Antihypertensives
- C03 Diuretics
- C04 Peripheral vasodilators
- C05 Vasoprotectives
- C07 Beta blocking agents
- C08 Calcium channel blockers
- C09 Agents acting on the renin–angiotensin system
- C10 Lipid modifying agents
|
Other ATC codes |
---|
|
ATC code C08 Calcium channel blockers is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup C08 is part of the anatomical group C Cardiovascular system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC08.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
- C08CA01 Amlodipine
- C08CA02 Felodipine
- C08CA03 Isradipine
- C08CA04 Nicardipine
- C08CA05 Nifedipine
- C08CA06 Nimodipine
- C08CA07 Nisoldipine
- C08CA08 Nitrendipine
- C08CA09 Lacidipine
- C08CA10 Nilvadipine
- C08CA11 Manidipine
- C08CA12 Barnidipine
- C08CA13 Lercanidipine
- C08CA14 Cilnidipine
- C08CA15 Benidipine
- C08CA16 Clevidipine
- C08CA17 Levamlodipine
- C08CA51 Amlodipine and celecoxib
- C08CA55 Nifedipine, combinations
C08CX Other selective calcium channel blockers with mainly vascular effects
- C08CX01 Mibefradil
C08D Selective calcium channel blockers with direct cardiac effects
- C08DA01 Verapamil
- C08DA02 Gallopamil
- C08DA51 Verapamil, combinations
- C08DB01 Diltiazem
C08E Non-selective calcium channel blockers
C08EA Phenylalkylamine derivatives
- C08EA01 Fendiline
- C08EA02 Bepridil
C08EX Other non-selective calcium channel blockers
- C08EX01 Lidoflazine
- C08EX02 Perhexiline
C08G Calcium channel blockers and diuretics
C08GA Calcium channel blockers and diuretics
- C08GA01 Nifedipine and diuretics
- C08GA02 Amlodipine and diuretics
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code C08". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QC08". WHO Collaborating Centre for Drug Statistics Methodology.
Calcium | VDCCsTooltip Voltage-dependent calcium channels | |
---|
|
---|
Potassium | VGKCsTooltip Voltage-gated potassium channels | |
---|
IRKsTooltip Inwardly rectifying potassium channel | Blockers | |
---|
Activators | - GIRKTooltip G protein-coupled inwardly rectifying potassium channel-specific: ML-297 (VU0456810)
|
---|
|
---|
KCaTooltip Calcium-activated potassium channel | |
---|
K2PsTooltip Tandem pore domain potassium channel | |
---|
|
---|
Sodium | VGSCsTooltip Voltage-gated sodium channels | |
---|
ENaCTooltip Epithelial sodium channel | |
---|
ASICsTooltip Acid-sensing ion channel | |
---|
|
---|
Chloride | CaCCsTooltip Calcium-activated chloride channel | |
---|
CFTRTooltip Cystic fibrosis transmembrane conductance regulator | |
---|
Unsorted | |
---|
|
---|
Others | TRPsTooltip Transient receptor potential channels | |
---|
LGICsTooltip Ligand gated ion channels | |
---|
|
---|
See also: Receptor/signaling modulators • Transient receptor potential channel modulators |